Development code · Small Molecule
TD-9855
TD-9855 is a development code for Ampreloxetine, developed by Theravance Biopharma, Inc..
- Status
- Discontinued for Multiple System Atrophy
- Mechanism
- NET Reuptake inhibitor
- Developer
- Theravance Biopharma, Inc.
Programs
- Ampreloxetine for Multiple System AtrophyDiscontinuedDiscontinued
- Ampreloxetine for Attention-deficit/hyperactivity disorderDiscontinuedDiscontinued
- Ampreloxetine for FibromyalgiaDiscontinuedDiscontinued
Also known as
- TD 9855
- ampreloxetine
- 1227056-84-9
- 4-[2-[(2,4,6-trifluorophenoxy)methyl]phenyl]piperidine